Nanoparticle formation: A modular high pressure system to enhance biopharmaceutical properties of poorly soluble drugs

Pharmaceutical Technology

Volumn 30, Issue 3, 2006, Pages 96-108

  Shah, Umang ^a   Vemararapu, Chandra ^b   Askins, Vanessa ^b   Lodaya, Mayur ^b   Elzinga, Paul ^b   Mollan Jr , Matthew J ^b  

^a PFIZER INC   (United States)

^b PFIZER

Author keywords

[No Author keywords available]

Indexed keywords

CAVITATION; DRUG PRODUCTS; HIGH PRESSURE EFFECTS; SUSPENSIONS (FLUIDS);

HIGH-PRESSURE SYSTEMS; MODEL COMPOUNDS; SHEAR FORCES;

NANOSTRUCTURED MATERIALS;

AEROSIL; CROSCARMELLOSE SODIUM; DOCUSATE SODIUM; DODECYL SULFATE SODIUM; HYDROXYPROPYLCELLULOSE; LACTOSE; MAGNESIUM STEARATE; MICROCRYSTALLINE CELLULOSE; NANOCAPSULE; NANOPARTICLE; NAPROXEN; POLOXAMER; POLYSORBATE 80; POVIDONE; SILICON DIOXIDE;

ANIMAL EXPERIMENT; DOG; DRUG CAPSULE; DRUG MANUFACTURE; DRUG SOLUBILITY; DRUG STABILITY; FORCE; NANOTECHNOLOGY; NONHUMAN; PHYSICAL CHEMISTRY; REVIEW; SHEAR STRESS; TABLET;

EID: 33748940917     PISSN: 15432521     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (11)

1. H.W. Bosch et al., "Process for Preparing Therapeutic Compositions Containing Nanoparticles," US Patent No. 5,510,118 (1996).
2. G.G. Liversidge et al., "Methods of Making Nanocrystalline Formulations of HIV Protease Inhibitors using Cellulosic Surface Stabilizers," US Patent 6,068,858 (2000).
3. R.H. Muller, "Preparation and Physical Properties of Nanosuspensions (Dissocubes) of Poorly Soluble Drugs," Proc. Intern. Symp. Control. Rel. Bioact. Mater. 25 (1998).
4. G.G. Liversidge et al., "Surface Modified Anticancer Nanoparticles," US Patent 5,399,363 (1995).
5. D.E. Englund and E.D. Johansson, "Oral versus Vaginal Absorption in Oestradiol in Postmenopausal Women: Effects of Different Particle Size" Ups. J. Med. Sci. 86 (3), 297-307 (1981).
6. N. Kondo et al., "Improved Oral Absorption of a Poorly Water Soluble Drug, HO-221, in Experimental Animals," Biol. Pharm. Bull. 16, 796-800 (1993).
7. G.G. Liveridge and K.C. Cundy, "Particle Size Reduction for Improvement of Oral Bioavailability of Hydrophobic Drugs, I: Absolute Oral Bioavailability of Nanocrystalline Donazol in Beagle Dogs," Int. J. of Pharm. 125, 91-97 (1995).
8. BEE, Int. Electronic reference, retrieved Nov. 6, 2005, from http://www.beei.com/index.html.
9. T. Shechter et al., "Processing Product Components," US Patent 6,443,610 B1 (2002).
10. T. Shechter, "Forming Emulsions," US Patent 5720551 A (1998).
11. R.J. Hunter, Introduction to Modern Colloid Science (Oxford: Oxford University Press, 1993).